Diabetes may be a consequence of pancreatic cancer, preceding cancer diagnosis. The underlying mechanism is the release of exosomes delivering adrenomedullin to β cells, inducing endoplasmic reticulum stress and perturbations in the unfolded protein response, leading to β-cell dysfunction and death. This knowledge could lead to improved diagnostic strategies for pancreatic cancer.
CITATION STYLE
Korc, M. (2015). Pancreatic cancer-associated diabetes is an “exosomopathy.” Clinical Cancer Research, 21(7), 1508–1510. https://doi.org/10.1158/1078-0432.CCR-14-2990
Mendeley helps you to discover research relevant for your work.